CardioVascular and Interventional Radiology (CVIR) is an official journal of
Founded in 1978 by Professors Herbert L. Abrams and Eberhard Zeitler,
CVIR is the longest-running journal in the field of vascular and interventional radiology.
CIRSE Members have unlimited online access to all CVIR articles. To access the full text articles, log in with the credentials for myCIRSE.*
* Please note Chrome users are currently experiencing problems accessing CVIR. If you experience access problems, we recommend first trying another browser (Mozilla Firefox, Edge, Internet Explorer, Safari etc.). Springer is looking into solving the issue. Thank you for your understanding.
The new CIRSE standards of practice encompasses up-to-date clinical and technical aspects in performing safe and appropriate arterial access for interventions.
Many thanks to Elika Kashef and the entire writing group for creating this important document! We’re making this essential SOP open access through March 16. Enjoy it and pass it on to your colleagues!
CIRSE fully supports a new regulatory framework for medical devices that ensures that only safe and effective devices enter or remain on the European market.
However, considering potential risks linked to the legal transition in progress, the society urges all stakeholders to take actions that will allow the avoidance of negative consequences for patients and ensure the continuous availability of devices.
Mechanical thrombectomy for PE: Acceptable outcomes of this single center retrospective study on 27 patients with intermediate and high-risk acute PE who didn’t improve or had contraindications to lysis; in-hospital mortality was 7.4% and median ICU stay was 2 days for patients admitted for acute PE.
CVIR's latest special section was curated by guest editors Professors Laura Crocetti and Thierry de Baère.
Professors Crocetti and de Baère commissioned nine articles, which they say in their introduction editorial "cover the most recent knowledge and scientific evidence about radioembolization technique, patient selection and clinical outcomes."
The CIRSE 2022 FIRST@CIRSE sessions, featured original papers and brand-new, ground-breaking IR studies presented by the researchers themselves.
At CVIR, we are delighted to share the good news that this year four of these presentations have already been published in the journal.
We are thrilled to announced, that for the second consecutive year CVIR’s impact factor rose in 2021 to 2.797, from 2.740 in 2020!
We are proud to host such high-quality articles and tenacious authors. Thank you all for making CVIR your IR journal of choice!
Are you about to submit your paper to CVIR?
Click here to find out which biological/biomedical reporting checklists are mandatory when submitting to CVIR.
CIRSE has a journal family!
Good papers submitted to CVIR and not accepted due to CVIR's limited page budget will be automatically transferred to CVIR Endovascular for consideration.